콘텐츠로 건너뛰기
Merck
  • Revealing the Specificity of Human H1 Influenza A Viruses to Complex N-Glycans.

Revealing the Specificity of Human H1 Influenza A Viruses to Complex N-Glycans.

JACS Au (2023-04-04)
Angeles Canales, Javier Sastre, Jose M Orduña, Cindy M Spruit, Javier Pérez-Castells, Gema Domínguez, Kim M Bouwman, Roosmarijn van der Woude, Francisco Javier Cañada, Corwin M Nycholat, James C Paulson, Geert-Jan Boons, Jesús Jiménez-Barbero, Robert P de Vries
초록

Influenza virus infection remains a threat to human health since viral hemagglutinins are constantly drifting, escaping infection and vaccine-induced antibody responses. Viral hemagglutinins from different viruses display variability in glycan recognition. In this context, recent H3N2 viruses have specificity for α2,6 sialylated branched N-glycans with at least three N-acetyllactosamine units (tri-LacNAc). In this work, we combined glycan arrays and tissue binding analyses with nuclear magnetic resonance experiments to characterize the glycan specificity of a family of H1 variants, including the one responsible for the 2009 pandemic outbreak. We also analyzed one engineered H6N1 mutant to understand if the preference for tri-LacNAc motifs could be a general trend in human-type receptor-adapted viruses. In addition, we developed a new NMR approach to perform competition experiments between glycans with similar compositions and different lengths. Our results point out that pandemic H1 viruses differ from previous seasonal H1 viruses by a strict preference for a minimum of di-LacNAc structural motifs.

MATERIALS
제품 번호
브랜드
제품 설명

Roche
Neuraminidase (Sialidase), from Vibrio cholerae